RN Mobile Menu

Search form


Rheumatoid Arthritis

Rheumatoid Arthritis


Tocilizumab may be associated with increasing LDL cholesterol in rheumatoid arthritis, but a new study shows that it is not associated with increased cardiovascular risk.

Arthritis (©Fineart1/Shutterstock.com)

Rheumatoid arthritis patients with lower MBDA scores respond better to triple therapy vs. methotrexate and infliximab combo.

Osteoporosis (©JavierRegueiro/Shutterstock.com)

For the first time in seven years, the ACR has new treatment recommendations for glucocorticoid-induced osteoporosis. In this slideshow, we highlight the new guidelines.


The severity of long-term chronic pain that impedes daily life seems to be associated with higher mortality, researchers report.


The biosimilar adalimumab-atto is equivalent to its reference product — which it slightly outperformed in this trial.


This study is among the first to show that aggressive treatment of early rheumatoid arthritis with biologic DMARDs benefits high-risk patients.

(Synovial joint anatomy abstract. ©Tefi/Shutterstock.com)

The orally administered once-daily peficitinib without concomitant use of methotrexate reduces symptoms of rheumatoid arthritis in trial.


Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.